Uterine Liomyoma. Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Letrozole tablet, 2/5 mg, daily for 90 days.
Treatment - Drugs
Letrozole tablet, 2/5 mg, daily for 90 days
Sponsors
Vice chancellor for Research of Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 51 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : pre menopause patients who have symptomatic liomyomatos equivalent or larger than 3 cm. Exclusion criteria: patients who have received hormonal therapy; patients who have severe medical disorders; patients who have surgical treatment of myoma.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine leiomyomas size. Timepoint: before &90 days after 90 days treatment. Method of measurement: sonography.;Uterine size. Timepoint: before &90 days after 90 days treatment. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| FSH-LH. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Stradiol. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Ferritine. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Patients symptoms. Timepoint: before & after 90 days treatment. Method of measurement: questionnaire.;Hemoglobin. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mansoureh Samimi
Kashan University of Medical sciences
Outcome results
None listed